March 27, 2013
Gothenburg, Sweden, - Denator AB announced today that the company’s heat-stabilization system has been demonstrated to be compatible with MALDI imaging analysis. The preservation of sample components prior to MALDI imaging analysis is crucial to accurately measure the distribution and abundance of biological molecules in organs. During downstream analysis, the presence of metabolites, drug compounds [...]
Medicyte GmbH signs agreement with Life Technologies to develop next generation upcyte®
March 27, 2013
Various data, already presented at academic meetings, indicates that Medicyte’s upcyte® hepatocytes combine the benefits of quantity (generation of up to 2000 vials per donor) with the quality of primary hepatocytes. The new generation of upcyte® hepatocytes show more comparable results to primary cells in in-vitro assays (such as CYP 3A4-Induction, genotoxicity or hepato- and [...]
Trovagene Launches Urine-Based HPV Test
March 27, 2013
SAN DIEGO, -- Trovagene, Inc. (NASDAQ: TROV), today announced the commercial availability of its urine-based HPV-HR (high-risk) assay, a molecular human papillomavirus (HPV) test. The non-invasive test is designed to accurately identify the presence or absence of 15 known high-risk HPV strains using proprietary DNA sequences. Approximately 20 million Americans carry HPV, with six million [...]
March 27, 2013
SHANGHAI, -- Life Technologies Corporation (NASDAQ: LIFE) today announced that its Applied Biosystems 3500xL Dx Genetic Analyzer has been approved by China's State Food and Drug Administration (SFDA) for clinical diagnostic use in China and the launch of 10 Assays from its joint venture with Daan Gene. The development marks a major extension of Life [...]
New DNA Test Cuts Time to Find Horsemeat in Food from Two Days to Less than Four Hours
March 27, 2013
A new DNA test launched today cuts the time it takes to find horsemeat in food from two days to less than four hours. The process was developed by QIAGEN, the world's leading provider of molecular sample and assay technologies. The new testing method can detect in real time even minute traces of horsemeat (
Illumina Technology Enables Findings of the Collaborative Oncological Gene-Environment Study (COGS)
March 27, 2013
SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN) announced that its iCOGS custom array was used to identify genetic variants related to breast, ovary and prostate cancer as part of the Collaborative Oncological Gene-Environment Study (COGS), the results of which were published today in Nature Genetics and other leading journals.1 Developed in collaboration with four large [...]
Novel sample pretreatment unit for heavy metal analysis
March 27, 2013
AppliTek launches a unique solution for accurately determining the total metal content in water bodies. The novel pretreatment system, designed as an add-on unit for AppliTek’s VPA® Series of Voltammetric Process Analyzers, allows to safely and conveniently process incoming samples with concentrated acids and oxidizing agents. Accuracy, precision and stability of results are very critical [...]
BD Enters Pharmaceutical Industry with New Line of Generic Prefilled Injectable Products
March 27, 2013
Franklin Lakes, NJ – BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, today announced that the U.S. Food and Drug Administration (FDA) has approved the first drug to be offered in the just-launched BD Simplist™ ready-to-administer, line of prefilled generic injectables. BD Simplist prefilled injectables will be commercialized and manufactured by [...]
March 27, 2013
GAITHERSBURG, Md. & SHIN-YOKOHAMA, Japan -- MEDINET Co. Ltd. (TSE: #2370) and MaxCyte, Inc. announce the publication of the results of their scientific collaboration demonstrating that the use of MaxCyte’s cell loading technology results in 5 – 20 fold enhancement in potency of dendritic cell vaccines. The manuscript entitled ‘Clinical scale electroloading of mature dendritic [...]
Neogen reports 27% increase in quarterly net income
March 26, 2013
LANSING, Mich.,– Neogen Corporation (Nasdaq: NEOG) announced today that its net income for the third quarter of FY 2013, which ended Feb. 28, increased 27% to $6,652,000, or $0.27 per share, compared to the prior year’s third quarter net income of $5,244,000, or $0.22 a share. Year to date, nine-month net income increased 22% to [...]
